US-based collaborative healthcare software developer Iora Health closed a $75m series D round yesterday that featured GE Ventures, the corporate venturing subsidiary of conglomerate General Electric.
The round was led by Temasek, the sovereign wealth fund of Singapore, with participation from F-Prime Capital, the investment arm of financial conglomerate Fidelity, as well as Rice Management Company, which manages the endowment fund of Rice University, and healthcare provider Humana.
Venture capital firms .406 Ventures, Flare Capital Partners, Khosla Ventures and Polaris Partners also contributed capital.
Iora Health operates a health system and plaform dubbed Chirp that offers patients access to transparent medical records, educational offerings and the ability to contact healthcare professionals through a teleservice that includes phone, text message and email.
The company has opened 34 practices across 11 US locations to date and will put the series D funding towards further expansion. The money will also support continued development of Chirp.
Iora Health has now raised approximately $124m in funding altogether. GE Ventures also took part in a $28m series C round in January 2015, alongside Rice Management Company, Fidelity Biosciences (since restructured into F-Prime Capital), Khosla Ventures, .406 Ventures and Polaris Partners.
Other investors in Iora include Tony Hsieh, chief executive of e-commerce company Zappos, who took part in a $14m series B round in 2013 alongside Fidelity Biosciences, Polaris Partners and .406 Ventures.